Lab
Bayou Tox, LLC
Bayou Tox, LLC was paid $7.70M by Medicaid between Nov 2019 and Dec 2024, across 124 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 65% of everything it billed.
33Billing provider infoBAYOU TOX, LLC
GONZALES, LA 70737
GONZALES, LA 70737
33aNPI1952869612assigned 03/12/2019
33bProvider typeClinical Medical Laboratory
28Total paid$7.70M
24GClaims406,326
24DCodes billed124
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Louisiana
Rank by total paid#9 of 66
Median peer was paid$253K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILSON, ROBERT controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 149 | $4K | |
| 2020 | 58,945 | $907K | |
| 2021 | 66,086 | $1.81M | |
| 2022 | 75,411 | $2.05M | |
| 2023 | 132,383 | $1.71M | |
| 2024incomplete | 73,352 | $1.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 65% | 108,017 | 54,191 | $5.01M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 21% | 60,270 | 16,305 | $1.63M |
| 80050 | General health panel | 2.0% | 9,079 | 7,379 | $155K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.0% | 1,743 | 1,462 | $78K |
| 80053 | Comprehensive metabolic panel | 1.0% | 18,675 | 14,217 | $78K |
| 86701 | <1% | 16,810 | 12,912 | $70K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,627 | 14,261 | $61K |
| 81235 | <1% | 1,291 | 811 | $58K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,544 | 2,166 | $46K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,545 | 2,166 | $46K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,296 | 3,206 | $46K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,522 | 2,153 | $45K |
112 more codes
| 86780 | <1% | 8,184 | $44K | |
| 81001 | <1% | 20,372 | $31K | |
| 86592 | <1% | 11,352 | $27K | |
| 80061 | Lipid panel | <1% | 5,582 | $26K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,623 | $20K |
| 86703 | <1% | 2,883 | $18K | |
| 84403 | <1% | 1,553 | $18K | |
| 80074 | <1% | 2,866 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,179 | $13K |
| 84439 | <1% | 3,656 | $12K | |
| 82607 | <1% | 1,571 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,335 | $10K |
| 81025 | <1% | 2,926 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 291 | $9K |
| 84481 | <1% | 1,753 | $8K | |
| 82728 | <1% | 1,845 | $8K | |
| 84270 | <1% | 721 | $7K | |
| 82670 | <1% | 546 | $7K | |
| 87522 | Neg quan hep c or qual rna | <1% | 567 | $6K |
| 84153 | <1% | 741 | $5K | |
| 83550 | <1% | 1,878 | $5K | |
| 83001 | <1% | 538 | $5K | |
| 82627 | <1% | 433 | $5K | |
| 83002 | <1% | 508 | $5K | |
| 87536 | <1% | 157 | $4K | |
| 80076 | <1% | 5,094 | $4K | |
| 83540 | <1% | 1,843 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,001 | $3K |
| 83735 | <1% | 1,107 | $3K | |
| 84144 | <1% | 181 | $2K | |
| 82746 | <1% | 494 | $2K | |
| 84146 | <1% | 178 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 41 | $2K |
| 85651 | <1% | 1,286 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,583 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 92 | $2K |
| 84550 | <1% | 1,112 | $2K | |
| 81003 | <1% | 3,024 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 178 | $2K |
| 82043 | <1% | 681 | $2K | |
| 84100 | <1% | 844 | $1K | |
| 82570 | <1% | 661 | $1K | |
| 86689 | <1% | 264 | $1K | |
| 83930 | <1% | 353 | $1K | |
| 84702 | <1% | 191 | $932.23 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 55 | $892.16 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 66 | $440.30 |
| 83970 | <1% | 30 | $430.98 | |
| 84480 | <1% | 360 | $427.00 | |
| 84156 | <1% | 193 | $258.63 | |
| 80164 | <1% | 42 | $241.50 | |
| 84436 | <1% | 343 | $223.61 | |
| 84478 | <1% | 1,273 | $218.60 | |
| 85060 | <1% | 101 | $185.45 | |
| 82465 | <1% | 1,280 | $172.79 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 21 | $153.39 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 248 | $148.16 |
| 84704 | <1% | 18 | $137.30 | |
| 85007 | <1% | 906 | $124.57 | |
| 84479 | <1% | 67 | $98.31 | |
| 86593 | <1% | 31 | $90.19 | |
| 82248 | <1% | 131 | $83.74 | |
| 84460 | <1% | 284 | $76.91 | |
| 84450 | <1% | 285 | $75.04 | |
| 82977 | <1% | 80 | $65.28 | |
| 84132 | <1% | 263 | $45.24 | |
| 82310 | <1% | 260 | $44.58 | |
| 86140 | <1% | 37 | $43.75 | |
| 82040 | <1% | 365 | $41.75 | |
| 86376 | <1% | 21 | $39.72 | |
| 82565 | <1% | 244 | $37.16 | |
| 82435 | <1% | 244 | $33.36 | |
| 82947 | <1% | 259 | $32.45 | |
| 82374 | <1% | 220 | $32.32 | |
| 84295 | <1% | 244 | $30.24 | |
| 84520 | <1% | 245 | $28.68 | |
| 85027 | <1% | 18 | $16.23 | |
| 84155 | <1% | 269 | $10.53 | |
| 84075 | <1% | 209 | $8.72 | |
| 82247 | <1% | 252 | $4.96 | |
| 80348 | 0% | 74 | $0.00 | |
| 80338 | 0% | 1,766 | $0.00 | |
| 80361 | 0% | 1,752 | $0.00 | |
| 80373 | 0% | 1,751 | $0.00 | |
| 80347 | 0% | 1,688 | $0.00 | |
| 80364 | 0% | 1,751 | $0.00 | |
| 80370 | 0% | 1,746 | $0.00 | |
| 80323 | 0% | 1,063 | $0.00 | |
| 80336 | 0% | 1,058 | $0.00 | |
| 80354 | 0% | 762 | $0.00 | |
| 80356 | 0% | 1,753 | $0.00 | |
| 80337 | 0% | 1,687 | $0.00 | |
| 80346 | 0% | 1,064 | $0.00 | |
| 80369 | 0% | 912 | $0.00 | |
| 80365 | 0% | 64 | $0.00 | |
| 80372 | 0% | 64 | $0.00 | |
| 80362 | 0% | 981 | $0.00 | |
| 80325 | 0% | 74 | $0.00 | |
| 80360 | 0% | 64 | $0.00 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 1,293 | $0.00 |
| 80377 | 0% | 15 | $0.00 | |
| 80353 | 0% | 2,025 | $0.00 | |
| 80349 | 0% | 1,760 | $0.00 | |
| 80324 | 0% | 1,689 | $0.00 | |
| 80376 | 0% | 596 | $0.00 | |
| 80359 | 0% | 1,709 | $0.00 | |
| 80367 | 0% | 64 | $0.00 | |
| 99000 | 0% | 363 | $0.00 | |
| 80368 | 0% | 64 | $0.00 | |
| 80357 | 0% | 978 | $0.00 | |
| 80358 | 0% | 64 | $0.00 | |
| 80363 | 0% | 981 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILSON, ROBERT (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Covenant Family Practice, PC | Clarksville, TN | $4.98M |
| Smile Center for Kids PLLC | El Paso, TX | $2.10M |
| Smile Center for Kids I PLLC | El Paso, TX | $1.97M |
| Abc Family Counseling, INC. | Anoka, MN | $385K |
| Lakeview Local Schools | Cortland, OH | $218K |
| Piedmont Interventional Pain Care, PA | Salisbury, NC | $150K |
| Wilson Family Eyecare PS | Prosser, WA | $94K |
| Robert L. Wilson DDS, P.A. | Heber Springs, AR | $41K |
| Kenton City Office of Auditor | Kenton, OH | $32K |
| Anderson Creek Emergency Services INC. | Spring Lake, NC | $15K |
| DR. Robert a Wilson, MD PA | Greenville, SC | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.